APME ethical code
The code of the Association of Pharmaceutical Manufacturers in Estonia on the Promotion of Prescription Medicines and Cooperation with Healthcare Professionals is based on the EFPIA code on the Promotion of Prescription-Only Medicines to, and Interaction with, Healthcare Professionals, adopted by the EFPIA Board on 05.10.2007.
APME supports competition among pharmaceutical companies. The APME Code is not intended to restrain the promotion of medicinal products to, or limit interactions with, healthcare professionals in a manner that is detrimental to fair competition. Instead, the code seeks to ensure that pharmaceutical companies conduct such promotion and interaction in a truthful manner, avoiding deceptive practices and potential conflicts of interest with healthcare professionals, and in compliance with applicable laws and regulations. The APME Code therfore aims to foster an environment where the general public can be confident that choices regarding their medicines are being made on the basis of the merits of each product and the healthcare needs of patients.
APME Etihics Code General Assembly decision applicable from 08.12.2022 and Annex C1. Data disclosure form